NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 654,534 shares, a growth of 631.2% from the June 15th total of 89,521 shares. Approximately 28.6% of the company’s stock are short sold. Based on an average daily volume of 18,460,916 shares, the days-to-cover ratio is currently 0.0 days.

Insider Buying and Selling at NewGenIvf Group

In other news, major shareholder Financial Lp Hrt sold 28,439 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $2.40, for a total value of $68,253.60. Following the sale, the insider directly owned 18,187 shares in the company, valued at approximately $43,648.80. This trade represents a 60.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 31.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on NIVF shares. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a research note on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

NewGenIvf Group Stock Performance

Shares of NASDAQ:NIVF traded down $0.04 during trading on Monday, reaching $1.35. The stock had a trading volume of 40,209 shares, compared to its average volume of 985,796. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. The business has a fifty day moving average price of $2.39 and a 200-day moving average price of $8.72. NewGenIvf Group has a 1-year low of $1.19 and a 1-year high of $624.60.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($861.72) EPS for the quarter. The company had revenue of $1.42 million during the quarter. As a group, equities analysts forecast that NewGenIvf Group will post 14.22 EPS for the current year.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.